Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-046002
Filing Date
2013-08-14
Accepted
2013-08-14 18:29:15
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q v351478_10q.htm 10-Q 451165
2 EXHIBIT 31.1 v351478_ex31-1.htm EX-31.1 9135
3 EXHIBIT 32.1 v351478_ex32-1.htm EX-32.1 3878
  Complete submission text file 0001144204-13-046002.txt   8078070

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT xtls-20130630.xml EX-101.INS 858570
5 XBRL TAXONOMY EXTENSION SCHEMA xtls-20130630.xsd EX-101.SCH 52525
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xtls-20130630_cal.xml EX-101.CAL 59570
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xtls-20130630_def.xml EX-101.DEF 241648
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xtls-20130630_lab.xml EX-101.LAB 372763
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xtls-20130630_pre.xml EX-101.PRE 297919
Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address 630 FIFTH AVENUE SUITE 2600 NEW YORK NY 10020 201-934-2000
Xstelos Holdings, Inc. (Filer) CIK: 0001540145 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-54646 | Film No.: 131039804
SIC: 2834 Pharmaceutical Preparations